Pulmonary tumor embolism: A retrospective study over a 30-year period.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
03
2021
accepted:
26
07
2021
entrez:
11
8
2021
pubmed:
12
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Pulmonary tumor embolism (PTE) is difficult to detect before death, and it is unclear whether the discrepancy between antemortem clinical and postmortem diagnosis improves with the advance of the diagnostic technologies. In this study we determined the incidence of PTE and analyzed the discrepancy between antemortem clinical and postmortem diagnosis. We performed a retrospective autopsy study on patients with the history of malignant solid tumors from 1990 to 2020 and reviewed all the slides of the patients with PTE. We also analyzed the discrepancies between antemortem clinical and postmortem diagnosis in 1999, 2009 and 2019 by using the Goldman criteria. Goldman category major 1 refers to cases in which an autopsy diagnosis was the direct cause of death and was not recognized clinically, but if it had been recognized, it may have changed treatment or prolonged survival. We found 20 (3%) cases with PTE out of the 658 autopsy cases with solid malignancies. Out of these 20 cases, urothelial carcinoma (30%, 6/20) and invasive ductal carcinoma of the breast (4/20, 20%) were the most common primary malignancies. Seven patients with shortness of breath died within 3-17 days (average 8.4±2.2 days) after onset of the symptoms. Pulmonary embolism was clinically suspected in seven out of twenty (35%, 7/20) patients before death, but only two patients (10, 2/20) were diagnosed by imaging studies before death. The rate of Goldman category major 1 was 13.2% (10/76) in 1999, 7.3% (4/55) in 2009 and 6.9% (8/116) in 2019. Although the rate of Goldman category major 1 appeared decreasing, the difference was not statistically significant. The autopsy rate was significantly higher in 2019 (8.4%, 116/1386) than in 2009 (4.4%, 55/1240). The incidence of PTE is uncommon. Despite the advances of the radiological techniques, radiological imaging studies did not detect the majority of PTEs. The discrepancy between the antemortem clinical and the postmortem diagnosis has not improved significantly over the past 30 years, emphasizing the value of autopsy.
Sections du résumé
BACKGROUND
Pulmonary tumor embolism (PTE) is difficult to detect before death, and it is unclear whether the discrepancy between antemortem clinical and postmortem diagnosis improves with the advance of the diagnostic technologies. In this study we determined the incidence of PTE and analyzed the discrepancy between antemortem clinical and postmortem diagnosis.
METHODS
We performed a retrospective autopsy study on patients with the history of malignant solid tumors from 1990 to 2020 and reviewed all the slides of the patients with PTE. We also analyzed the discrepancies between antemortem clinical and postmortem diagnosis in 1999, 2009 and 2019 by using the Goldman criteria. Goldman category major 1 refers to cases in which an autopsy diagnosis was the direct cause of death and was not recognized clinically, but if it had been recognized, it may have changed treatment or prolonged survival.
RESULTS
We found 20 (3%) cases with PTE out of the 658 autopsy cases with solid malignancies. Out of these 20 cases, urothelial carcinoma (30%, 6/20) and invasive ductal carcinoma of the breast (4/20, 20%) were the most common primary malignancies. Seven patients with shortness of breath died within 3-17 days (average 8.4±2.2 days) after onset of the symptoms. Pulmonary embolism was clinically suspected in seven out of twenty (35%, 7/20) patients before death, but only two patients (10, 2/20) were diagnosed by imaging studies before death. The rate of Goldman category major 1 was 13.2% (10/76) in 1999, 7.3% (4/55) in 2009 and 6.9% (8/116) in 2019. Although the rate of Goldman category major 1 appeared decreasing, the difference was not statistically significant. The autopsy rate was significantly higher in 2019 (8.4%, 116/1386) than in 2009 (4.4%, 55/1240).
CONCLUSIONS
The incidence of PTE is uncommon. Despite the advances of the radiological techniques, radiological imaging studies did not detect the majority of PTEs. The discrepancy between the antemortem clinical and the postmortem diagnosis has not improved significantly over the past 30 years, emphasizing the value of autopsy.
Identifiants
pubmed: 34379693
doi: 10.1371/journal.pone.0255917
pii: PONE-D-21-09732
pmc: PMC8357121
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0255917Déclaration de conflit d'intérêts
No authors have competing interests.
Références
Intern Med. 2004 May;43(5):420-2
pubmed: 15206557
J Am Soc Echocardiogr. 1992 Jul-Aug;5(4):439-43
pubmed: 1510861
BMC Pulm Med. 2018 Jul 11;18(1):112
pubmed: 29996818
BMC Pediatr. 2019 Jan 31;19(1):39
pubmed: 30704433
N Engl J Med. 1983 Apr 28;308(17):1000-5
pubmed: 6835306
Acta Clin Belg. 2006 Jan-Feb;61(1):30-4
pubmed: 16673614
Lung. 2010 Oct;188(5):441-3
pubmed: 20607269
Heart Vessels. 2014 Nov;29(6):873-7
pubmed: 24275907
BMJ Case Rep. 2012 Sep 30;2012:
pubmed: 23035163
Gan To Kagaku Ryoho. 2013 Apr;40(4):499-502
pubmed: 23848019
Arch Pathol Lab Med. 2012 Dec;136(12):1552-7
pubmed: 23194048
Curr Probl Diagn Radiol. 2014 Jul-Aug;43(4):227-31
pubmed: 24948215
Acad Emerg Med. 2002 Sep;9(9):957-9
pubmed: 12208686
Am J Respir Crit Care Med. 1997 Jun;155(6):2089-95
pubmed: 9196119
Intern Med. 2015;54(8):955-60
pubmed: 25876580
Acta Oncol. 1992;31(5):519-23
pubmed: 1419097
Jpn Circ J. 1997 Jan;61(1):82-6
pubmed: 9070964
Case Rep Oncol. 2013 Jun 22;6(2):331-8
pubmed: 23898277
Lung Cancer. 2011 Apr;72(1):132-5
pubmed: 21333371
Nuklearmedizin. 1998 Jun;37(4):153-5
pubmed: 9650217
Arch Pathol Lab Med. 1993 Aug;117(8):827-31
pubmed: 8343048
Fukuoka Igaku Zasshi. 2003 Jul;94(7):235-40
pubmed: 14509231
No Shinkei Geka. 1992 Sep;20(9):997-1001
pubmed: 1407367
Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Oct;31(10):1269-78
pubmed: 8271660
Z Gastroenterol. 2000 Mar;38(3):243-8
pubmed: 10768247
Ned Tijdschr Geneeskd. 1997 Mar 15;141(11):536-40
pubmed: 9190512
J Cardiol. 2006 Oct;48(4):227-32
pubmed: 17066627
JAMA. 1998 Oct 14;280(14):1273-4
pubmed: 9786381
Rev Mal Respir. 1995;12(1):62-5
pubmed: 7899672
Am J Med. 2003 Aug 15;115(3):228-32
pubmed: 12935829
Cancer. 1975 Oct;36(4):1473-82
pubmed: 1175142
Eur J Gastroenterol Hepatol. 2002 Jul;14(7):775-7
pubmed: 12169988
Dtsch Med Wochenschr. 2006 Mar 24;131(12):618-21
pubmed: 16544237
Respir Investig. 2014 May;52(3):199-202
pubmed: 24853022
Pneumologie. 1993 Oct;47(10):593-6
pubmed: 8259368
J Forensic Sci. 2016 Mar;61(2):555-558
pubmed: 27404631
Am J Med. 1968 Aug;45(2):271-90
pubmed: 4299069
Jpn J Radiol. 2009 Nov;27(9):381-4
pubmed: 19943151
Surg Pathol Clin. 2015 Jun;8(2):159-74
pubmed: 26065791
Forensic Sci Med Pathol. 2020 Mar;16(1):152-156
pubmed: 31691070
J Thorac Oncol. 2008 Dec;3(12):1482-3
pubmed: 19057276
Neth J Med. 2014 Jan;72(1):28-31
pubmed: 24457436
Hinyokika Kiyo. 1993 May;39(5):475-8
pubmed: 8322632
Can Respir J. 2002 Sep-Oct;9(5):347-50
pubmed: 12410327
Forensic Sci Int. 2000 Feb 28;108(3):215-21
pubmed: 10737468
Intern Med. 2016;55(17):2453-6
pubmed: 27580549
Respirology. 2000 Sep;5(3):297-9
pubmed: 11022995
Anaesthesist. 1991 Jul;40(7):407-9
pubmed: 1928716
Onkologie. 2004 Dec;27(6):566-8
pubmed: 15591717
J Thorac Imaging. 1999 Apr;14(2):135-7
pubmed: 10210489
Respiration. 1997;64(3):244-6
pubmed: 9154680
Nihon Kyobu Shikkan Gakkai Zasshi. 1994 May;32(5):491-6
pubmed: 8084107
Duodecim. 2010;126(18):2147-52
pubmed: 21072962
Breast J. 2000 Jul;6(4):273-275
pubmed: 11348379
An Sist Sanit Navar. 2015 May-Aug;38(2):339-43
pubmed: 26486545
J Postgrad Med. 2020 Jul-Sep;66(3):155-158
pubmed: 32675452
Pathol Res Pract. 2003;199(5):349-52
pubmed: 12908527
Intern Med. 2009;48(12):1057-60
pubmed: 19525598
J Intern Med. 1994 Nov;236(5):597-8
pubmed: 7964440
Hinyokika Kiyo. 2003 Mar;49(3):169-72
pubmed: 12728533
Arch Pathol Lab Med. 1992 Feb;116(2):131-4
pubmed: 1733403
IJU Case Rep. 2020 Jun 18;3(5):161-165
pubmed: 32914059
Eur J Cancer. 1991;27(4):495-8
pubmed: 1827728
Nihon Kokyuki Gakkai Zasshi. 2002 Nov;40(11):910-4
pubmed: 12645114
Int J Gynecol Cancer. 2006 Mar-Apr;16(2):914-6
pubmed: 16681785
Pediatr Pathol. 1994 Sep-Oct;14(5):763-70
pubmed: 7808974
Z Gastroenterol. 2001 Aug;39(8):583-6
pubmed: 11558062
Chest. 1999 Nov;116(5):1489-90
pubmed: 10559123
Pneumologie. 2004 Jun;58(6):400-3
pubmed: 15216432
Nihon Kokyuki Gakkai Zasshi. 2011 Aug;49(8):577-82
pubmed: 21894772
Respirol Case Rep. 2016 Dec 05;5(1):e00209
pubmed: 28031842
Pathol Int. 2020 Sep;70(9):680-685
pubmed: 32638479
Praxis (Bern 1994). 2014 Sep 3;103(18):1081-3
pubmed: 25183617
Hinyokika Kiyo. 2004 Apr;50(4):279-81
pubmed: 15188624
In Vivo. 2018 Mar-Apr;32(2):337-343
pubmed: 29475918
South Med J. 2001 Oct;94(10):1030-2
pubmed: 11702817
Chest. 1997 Apr;111(4):1122-5
pubmed: 9106600
World J Gastroenterol. 2005 Apr 21;11(15):2357-9
pubmed: 15818754
Int Cancer Conf J. 2020 Aug 19;10(1):15-19
pubmed: 33489695
Urology. 2016 Jul;93:e9-e11
pubmed: 27017904
Ned Tijdschr Geneeskd. 2009;153:A227
pubmed: 19785837
Pathol Int. 2007 Feb;57(2):96-100
pubmed: 17300674
Pathol Int. 2010 Mar;60(3):228-34
pubmed: 20403050
Med Health R I. 2010 Oct;93(10):308, 313-6
pubmed: 21284270
Hinyokika Kiyo. 2016 Sep;62(9):473-477
pubmed: 27760972
Eur Respir J. 2011 Aug;38(2):477-9
pubmed: 21804167
Virchows Arch. 2013 May;462(5):523-31
pubmed: 23536282
Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Jun;35(6):641-4
pubmed: 9294298
Pathol Res Pract. 2006;202(5):395-9
pubmed: 16488087